Literature DB >> 7999008

Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts.

H S Sharma1, H A van Heugten, M A Goedbloed, P D Verdouw, J M Lamers.   

Abstract

Angiotensin II (ANG II), a potent vasoconstricting peptide, may act as a growth factor for cardiac muscle cells and induce hypertrophy. We examined the molecular phenotype of neonatal rat cardiac fibroblasts in relation to ANG II by studying the expression pattern of three transcription factors (Egr-1, c-fos and c-jun) and the transforming growth factor-beta 1 (TGF-beta 1). ANG II did not affect cell proliferation and growth of serum deprived neonatal cardiac fibroblasts as predicted from their DNA and protein contents. The expression of Egr-1 and c-fos was induced as early as 15 min that reached maximal levels at 45 min and declined thereafter, whereas c-jun was induced at 45 min and remained elevated up to 2 hrs of ANG II addition. ANG II up-regulated the expression of TGF-beta 1, which became apparent after 1 hr of incubation and reached a plateau between 16-48 hrs. Our results indicate that ANG II transiently stimulates the expression of transcription factors, which may up-regulate TGF-beta 1, that in turn could contribute to the process of myocardial extra-cellular matrix remodeling in hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999008     DOI: 10.1006/bbrc.1994.2636

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.

Authors:  J Kyselovic; P Krenek; M Wibo; T Godfraind
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 2.  Regulation and functional significance of phospholipase D in myocardium.

Authors:  Y E Eskildsen-Helmond; H A Van Heugten; J M Lamers
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

3.  Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block.

Authors:  L Hein; M E Stevens; G S Barsh; R E Pratt; B K Kobilka; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice.

Authors:  T Matsusaka; H Katori; T Inagami; A Fogo; I Ichikawa
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 5.  Angiotensin II: biosynthesis, molecular recognition, and signal transduction.

Authors:  J F Riordan
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

6.  Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway.

Authors:  Alia Shatanawi; Tahira Lemtalsi; Lin Yao; Chintan Patel; Ruth B Caldwell; R William Caldwell
Journal:  Eur J Pharmacol       Date:  2014-10-30       Impact factor: 4.432

7.  Molecular remodelling in hypertrophied hearts from polyomavirus large T-antigen transgenic mice.

Authors:  E L Holder; A E Al Moustafa; L E Chalifour
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

8.  Cigarette smoke increases gastric ulcer size in part by an angiotensin II-mediated mechanism in rats.

Authors:  K Seno; J H Zhu; J D Barrett; P Eggena; O U Scremin; K Lam; J W Leung; F W Leung
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

9.  The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat.

Authors:  Kai Huang; Guizhu Dai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

10.  Expression and function of osteopontin in vascular adventitial fibroblasts and pathological vascular remodeling.

Authors:  Xin Jin; Guo-xiang Fu; Xiao-dong Li; Ding-liang Zhu; Ping-jin Gao
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.